{"ticker": {"uuid": "d29582b5-131a-4c61-95d8-f991742cd4e0", "symbol": "SNT", "name": "Syntara Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Why Is Syntara (ASX:SNT) Drawing Fresh Health Microcap Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPcTU1dGsxS1dtUFFVTmFBZUIzeElFUlExcS01WnNjMnBCZ1lrYmtiTGZBRWtiUUFuNmtXRTR4OWs0VWNPZ2xZb1JoM2dIU3RRWTJtaFNpeHVUekJDdnk4aFB4SmpMcW40R3U2R3J5TlNyM2dITEhtVnlVLU9yTmZvaWpXa0d2V3dXUTlMRFhPZkVGUTNuNHhXVkxqLWN2d0dGLV9fLU9Qemo?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T07:22:00+00:00", "published_display": "16 Jul 2026 07:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Ltd (SNT) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxQYWswUzRuU1RwRUk0ZXAtaHN1M1VBYXZEcmR5WjdHS282NFRieGNHU3lhM2FCandseVZFbGduWWZibGRhTWxTb1NGWkoxODNSWHJMTU9YWVpHamJoUUkxRENqWE1hb0I0V2dMcXF3M0xpVWlBYjBkVjNsLWtSNFQzS29oVHMxWC1OcXpHcTVSTDBRN0RLck8waXMzUUZWMFZfd2drS3hFLVF2VmFHc3h5RVZkSXhKQkUzN2NZWklzTEpXS3NDUW9FT3pyV1lLVE0yTnI0OGNsaUhvX1VxaGVKdVMzOFA1cGJnd0FwNlhBVVc4TVlQeU1zbmxQbWxFR2YtWU1EQnN6NzVPSjMwdzVwTzNfRklkbkZIRXFvMkwyNlpRTEZTLXc?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T02:35:53+00:00", "published_display": "15 Jul 2026 02:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara (ASX:SNT) Shares Gain Attention After Neuroinflammation Study Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQMmRZRUF6ZmI4TXVsRFV5RjNKZVR3MHpqQlBpbmdXRG5URWREZ2dNX09mbDJoSEdkbmdVRzRGZk10UzBMUnA2NHpDVFBsWFpRM0h5ODRZbHd2N0RzYW4xel9pRHRBUDRZUUtmUk1hWjdoMTlSUU1EYVJXY0hYdTBXRVhiLWJNR2pjTmxQbjFEOG5WWmpNOGszNnZUUER6bU9jWkFTNjQ1ZmV0NGhITU51VW9R?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara (ASX:SNT): Why Is the Biotech Company Expanding Its Listed Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPZHVsSGFpZGNraEIyMG84QUZuTF9EanByZjRneTRXYXRYcjF0OWxkWlJSR3VkblZMSnY2dHVISzNBcVpCdFpNYlVydlU4NEJjT0drbmlmNHVmczlBYU5oSWs5LVhrODF1NkhweXVMeWhWeU5ZTmhPdjJGd2I5Ym5leTVUSE92ZUlmc0liNXRPbnFEWFVNWHFncFhSQ2I1TnpyUDd6R3dlVW1Ic3hqcm5jT1lZVkltUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Secures A$10 Million Capital Injection to Advance Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMm94R0RpeWZmS3RtUVhRWW1STlRCcFBjRDJhNUF3bVp1SVIzeF80eUxWUDBPRUJLaVNoNW1xR1RmUFRHUm5SdHFxbHNJcGExRVEzNmRFTkFUckF2X0toLXBGUVFQQ3lILWxaeVZ2Rm5YYm9HX3lDcl9ua1hGSjBmNTlhMWh1UUt5WnJ4dnk1VVdDNWFGdGN6dHRaMHFXUktQV2JaQ0ZFdUpzemtubGFEalAyQVhqUQ?oc=5", "source_name": "Sharecafe", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Syntara (ASX:SNT) In A Good Position To Deliver On Growth Plans?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-28T08:00:00+00:00", "published_display": "28 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara\u2019s stock plunges 52% following FDA request for added trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPWE53eGdoMTI2VnpQQ25DVmU3Umo3aGI2SW1Bek4wNk5uMDItVFkwVW9sT0ttbnRIXzIxdkVON0hlV2N5UWgzQ2k1OTIxRlVYd214alFBZkNLT3RzYnZ2NkZhM2RKV3FfLXRzMExvVk1zdFJrN1hVTFpQaDBJektpYllQZjJnVFNBY3lVM3l2VHJaSTlKOVhKWHhtNEowMmZEQlJ4TWtEVQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-11T07:00:00+00:00", "published_display": "11 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited Schedules Investor Webinar Amidst Quarterly Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOUFozTk8wRnNrRW9LcXZMbVoweFZTUGhSYnp0dEhGYV91dnpxRnlZYks3a1F2ZkljR0dlT3BMQlJVaWhYcFBrRzMtNGRPV3VwUmY5YmZVQ1haenkwTTBZR2lHTHNPcWZMVlpHcG5FTmV3X0NQbzhtSlhaX2ZtdTRkMW1kb2xkVXk3QVhhV3RCTTdabzBaMk9VTDdFd3BlbnY5ZnpzQUtwUi01Y3lkUGJMVHN3VFJVRzJFTlE?oc=5", "source_name": "TipRanks", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited (ASX: SNT) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSGJWdGxQT2xCbHRNWEN1R2JfM1ZmZGpWSjlDOWxRLXpyeGJITTJPalBYT3lITWZqTnRrWHdUR2l4Y2ZxM2NsaVJlNHZtdHh2VW94VHozRnpuUXgzSkQ3WS0yRGc3REhMSGlET1A0T09GWTAyaXlrVkdsYkRYUnJTTy1LNi0wdjJT?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-12-23T08:45:28+00:00", "published_display": "23 Dec 2023 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SNT Stock Price and Chart \u2014 ASX:SNT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9VNTBjMjdjZF9wMjN0SmVNT2lLV3BoWERoaFVxX0hXa0xDTW1QWF9xVE1UaVFkTlRRb0VPM1plNV9WRVpvdjVKQlFvYWhhNVRMOGNHcEVpOA?oc=5", "source_name": "TradingView", "published_at": "2023-12-09T15:35:22+00:00", "published_display": "09 Dec 2023 15:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited (ASX:SNT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFAwX0NSWUFRSmc0S28yZ2o4WU5qZElYeFVLVHozU29EZF85WFpSbWlISWU1ZzZWdG0tOTJ0NHd2SmptamZsalJadUhwV3JTU1N6ZXJQaWNQbTYyN0RGel9YLURxYnVqckFnaVFGSUlEMnN5OU9YZEFtMQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-12-07T13:57:38+00:00", "published_display": "07 Dec 2023 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A name change and significant sale as Pharmaxis becomes Syntara", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOcUpYYlZkYUhteWREQ1h3alZNZlRjb0cxa0VpcllEVS1qaGhnTjk1LUFxVmVHZDlIakowU3VDcHdsMXYtcGhoVHJhMjVha1NvSDl4QXoyX1dDTE5wYUw3aElncklCNkt0N1pyZzF6VEtTR3o2OGhucndCckZwVlRMMW9BMGFLRlZncEt5QlU2aDE3c1F2VXh3VC1YUE04b3oz?oc=5", "source_name": "BiotechDispatch", "published_at": "2023-10-03T07:00:00+00:00", "published_display": "03 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Is Syntara (ASX:SNT) Drawing Fresh Health Microcap Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPcTU1dGsxS1dtUFFVTmFBZUIzeElFUlExcS01WnNjMnBCZ1lrYmtiTGZBRWtiUUFuNmtXRTR4OWs0VWNPZ2xZb1JoM2dIU3RRWTJtaFNpeHVUekJDdnk4aFB4SmpMcW40R3U2R3J5TlNyM2dITEhtVnlVLU9yTmZvaWpXa0d2V3dXUTlMRFhPZkVGUTNuNHhXVkxqLWN2d0dGLV9fLU9Qemo?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T07:22:00+00:00", "published_display": "16 Jul 2026 07:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Ltd (SNT) Stock Forum and Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxQYWswUzRuU1RwRUk0ZXAtaHN1M1VBYXZEcmR5WjdHS282NFRieGNHU3lhM2FCandseVZFbGduWWZibGRhTWxTb1NGWkoxODNSWHJMTU9YWVpHamJoUUkxRENqWE1hb0I0V2dMcXF3M0xpVWlBYjBkVjNsLWtSNFQzS29oVHMxWC1OcXpHcTVSTDBRN0RLck8waXMzUUZWMFZfd2drS3hFLVF2VmFHc3h5RVZkSXhKQkUzN2NZWklzTEpXS3NDUW9FT3pyV1lLVE0yTnI0OGNsaUhvX1VxaGVKdVMzOFA1cGJnd0FwNlhBVVc4TVlQeU1zbmxQbWxFR2YtWU1EQnN6NzVPSjMwdzVwTzNfRklkbkZIRXFvMkwyNlpRTEZTLXc?oc=5", "source_name": "Moomoo", "published_at": "2026-07-15T02:35:53+00:00", "published_display": "15 Jul 2026 02:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara (ASX:SNT) Shares Gain Attention After Neuroinflammation Study Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQMmRZRUF6ZmI4TXVsRFV5RjNKZVR3MHpqQlBpbmdXRG5URWREZ2dNX09mbDJoSEdkbmdVRzRGZk10UzBMUnA2NHpDVFBsWFpRM0h5ODRZbHd2N0RzYW4xel9pRHRBUDRZUUtmUk1hWjdoMTlSUU1EYVJXY0hYdTBXRVhiLWJNR2pjTmxQbjFEOG5WWmpNOGszNnZUUER6bU9jWkFTNjQ1ZmV0NGhITU51VW9R?oc=5", "source_name": "Kalkine", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara (ASX:SNT): Why Is the Biotech Company Expanding Its Listed Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPZHVsSGFpZGNraEIyMG84QUZuTF9EanByZjRneTRXYXRYcjF0OWxkWlJSR3VkblZMSnY2dHVISzNBcVpCdFpNYlVydlU4NEJjT0drbmlmNHVmczlBYU5oSWs5LVhrODF1NkhweXVMeWhWeU5ZTmhPdjJGd2I5Ym5leTVUSE92ZUlmc0liNXRPbnFEWFVNWHFncFhSQ2I1TnpyUDd6R3dlVW1Ic3hqcm5jT1lZVkltUQ?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Secures A$10 Million Capital Injection to Advance Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMm94R0RpeWZmS3RtUVhRWW1STlRCcFBjRDJhNUF3bVp1SVIzeF80eUxWUDBPRUJLaVNoNW1xR1RmUFRHUm5SdHFxbHNJcGExRVEzNmRFTkFUckF2X0toLXBGUVFQQ3lILWxaeVZ2Rm5YYm9HX3lDcl9ua1hGSjBmNTlhMWh1UUt5WnJ4dnk1VVdDNWFGdGN6dHRaMHFXUktQV2JaQ0ZFdUpzemtubGFEalAyQVhqUQ?oc=5", "source_name": "Sharecafe", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Syntara (ASX:SNT) In A Good Position To Deliver On Growth Plans?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-28T08:00:00+00:00", "published_display": "28 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara\u2019s stock plunges 52% following FDA request for added trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPWE53eGdoMTI2VnpQQ25DVmU3Umo3aGI2SW1Bek4wNk5uMDItVFkwVW9sT0ttbnRIXzIxdkVON0hlV2N5UWgzQ2k1OTIxRlVYd214alFBZkNLT3RzYnZ2NkZhM2RKV3FfLXRzMExvVk1zdFJrN1hVTFpQaDBJektpYllQZjJnVFNBY3lVM3l2VHJaSTlKOVhKWHhtNEowMmZEQlJ4TWtEVQ?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-11T07:00:00+00:00", "published_display": "11 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited Schedules Investor Webinar Amidst Quarterly Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOUFozTk8wRnNrRW9LcXZMbVoweFZTUGhSYnp0dEhGYV91dnpxRnlZYks3a1F2ZkljR0dlT3BMQlJVaWhYcFBrRzMtNGRPV3VwUmY5YmZVQ1haenkwTTBZR2lHTHNPcWZMVlpHcG5FTmV3X0NQbzhtSlhaX2ZtdTRkMW1kb2xkVXk3QVhhV3RCTTdabzBaMk9VTDdFd3BlbnY5ZnpzQUtwUi01Y3lkUGJMVHN3VFJVRzJFTlE?oc=5", "source_name": "TipRanks", "published_at": "2025-07-31T07:00:00+00:00", "published_display": "31 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited (ASX: SNT) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSGJWdGxQT2xCbHRNWEN1R2JfM1ZmZGpWSjlDOWxRLXpyeGJITTJPalBYT3lITWZqTnRrWHdUR2l4Y2ZxM2NsaVJlNHZtdHh2VW94VHozRnpuUXgzSkQ3WS0yRGc3REhMSGlET1A0T09GWTAyaXlrVkdsYkRYUnJTTy1LNi0wdjJT?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-12-23T08:45:28+00:00", "published_display": "23 Dec 2023 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SNT Stock Price and Chart \u2014 ASX:SNT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE9VNTBjMjdjZF9wMjN0SmVNT2lLV3BoWERoaFVxX0hXa0xDTW1QWF9xVE1UaVFkTlRRb0VPM1plNV9WRVpvdjVKQlFvYWhhNVRMOGNHcEVpOA?oc=5", "source_name": "TradingView", "published_at": "2023-12-09T15:35:22+00:00", "published_display": "09 Dec 2023 15:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Syntara Limited (ASX:SNT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTFAwX0NSWUFRSmc0S28yZ2o4WU5qZElYeFVLVHozU29EZF85WFpSbWlISWU1ZzZWdG0tOTJ0NHd2SmptamZsalJadUhwV3JTU1N6ZXJQaWNQbTYyN0RGel9YLURxYnVqckFnaVFGSUlEMnN5OU9YZEFtMQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2023-12-07T13:57:38+00:00", "published_display": "07 Dec 2023 13:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A name change and significant sale as Pharmaxis becomes Syntara", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOcUpYYlZkYUhteWREQ1h3alZNZlRjb0cxa0VpcllEVS1qaGhnTjk1LUFxVmVHZDlIakowU3VDcHdsMXYtcGhoVHJhMjVha1NvSDl4QXoyX1dDTE5wYUw3aElncklCNkt0N1pyZzF6VEtTR3o2OGhucndCckZwVlRMMW9BMGFLRlZncEt5QlU2aDE3c1F2VXh3VC1YUE04b3oz?oc=5", "source_name": "BiotechDispatch", "published_at": "2023-10-03T07:00:00+00:00", "published_display": "03 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 65, "total_relevant": 12, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 10, "score": 52, "total": 12, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 95, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.02, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -4.2, "twelve_week_move": -32.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.637093, "market_dynamics_buy_signal": false, "relative_strength": -27.581446, "fair_value_gap": -40.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.7829, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -4.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine Media", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "Moomoo", "count": 1}, {"label": "Kalkine", "count": 1}, {"label": "Sharecafe", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "TipRanks", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 12}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "95/100 classification confidence."}, {"label": "Company focus", "value": "12", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -4.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Is Syntara (ASX:SNT) Drawing Fresh Health Microcap Attention?"}], "updated_at": "2026-07-17T03:40:08.398161+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}